Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

1.31
Delayed Data
As of Apr 29
 -0.02 / -1.50%
Today’s Change
0.71
Today|||52-Week Range
4.13
+6.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2011
Quarter 2
2011
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues37.0K22.0K2.4M3.6M
 
 
 
 
 
Cost of Goods Sold124.0K65.0K2.2M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income-87.0K-43.0K263.0K1.7M
 
 
 
 
 
General Expenses2.5M3.2M4.1M4.6M
 
 
 
 
 
Research And Development1.0M1.3M586.0K1.0M
 
 
 
 
 
Total Operating Expenses2.6M3.2M6.3M6.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.6M-3.2M-3.9M-2.9M
 
 
 
 
 
Other Expenses822.0K421.0K-47.0K-3.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.8M-2.8M-3.9M-6.7M
 
 
 
 
 
Income Taxes0.000.00-5.0K-4.0K
 
 
 
Minority Interest-96.0K-261.0K0.000.00
 
 
 
Net Income-1.7M-2.5M-3.9M-6.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS395.9K76.1K14.8M17.2M
 
 
 
 
 
Shares To Calculate EPS Diluted395.9K76.1K14.8M17.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.20---$0.27--
 
 
 
EPS Diluted-$4.20-$33.00-$0.27-$0.39